Aim Recent studies have revealed that anti-phospholipase A2 receptor antibodies (aPLA2R-
ABs) may play a role in the diagnosis of idiopathic membranous nephropathy (IMN). We will …

Autoantibodies against phospholipase A2 receptor (PLA2R) are a sensitive and specific
marker for idiopathic membranous nephropathy (IMN). The aim of our study was to redefine …

Background Autoantibodies against-phospholipase A2 receptor (PLA2R) are specific
markers of idiopathic membranous nephropathy (iMN). Enzyme-linked immunosorbent …

Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …

Background Detection of M-type phospholipase A 2 receptor (PLA 2 R) can be used in
serologic diagnosis of idiopathic membranous nephropathy (IMN), but there are limited data …

Aim Serum levels of phospholipase A2 receptor antibody (PLA2R; SAb) and glomerular
deposits of PLA2R antigen (GAg) have been detected in patients with idiopathic …

Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful for affirming the diagnosis of
idiopathic membranous nephropathy (IMN). Time-resolved fluoroimmunoassay (TRFIA) is …

Background: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful in diagnosing
idiopathic membranous nephropathy (IMN). We investigated the clinical relevance of PLA2R …

Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Methods A total of 670 subjects including 374 IMN cases and 296 non-IMN controls were
included between January 2017 and January 2020. All clinical parameters were collected at …